Literature DB >> 477741

Analgesia produced by microinjection of baclofen and morphine at brain stem sites.

R A Levy, H K Proudfit.   

Abstract

Microinjection of either baclofen (1.5 microgram) or morphine (2.5 microgram), in equimolar doses (14 mM), at sites located in the caudal periaqueductal gray (PAG) resulted in a delay in tail flick latency (analgesia). The relative analgesic potency of baclofen among caudal PAG sites, however, did not correlate with that of morphine. Application of either drug into the caudal aspect of the cerebral aqueduct also produced analgesia, but neither agent caused analgesia when applied at PAG sites rostral to the interaural line. Baclofen also produced analgesia when microinjected in the lower brain stem at sites lateral to the midline in or near the nucleus gigantocellularis, but did not produce analgesia when applied on the midline at sites located within or near the raphe magnus. Conversely, morphine produced analgesia when applied locally at midline sites but not at sites located lateral to the midline. These data suggest that the analgesia produced by systemic administration of baclofen and morphine involves activation of different neuronal substrates.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477741     DOI: 10.1016/0014-2999(79)90102-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

1.  Effects of chronic constriction injury and spared nerve injury, two models of neuropathic pain, on the numbers of neurons and glia in the rostral ventromedial medulla.

Authors:  Mai Lan Leong; Rebecca Speltz; Martin Wessendorf
Journal:  Neurosci Lett       Date:  2016-02-06       Impact factor: 3.046

2.  Entanglement between thermoregulation and nociception in the rat: the case of morphine.

Authors:  Nabil El Bitar; Bernard Pollin; Elias Karroum; Ivanne Pincedé; Daniel Le Bars
Journal:  J Neurophysiol       Date:  2016-09-07       Impact factor: 2.714

3.  The use of opioids in children receiving intrathecal baclofen therapy.

Authors:  Giuliana Rizzo; Leonardo Bussolin; Lorenzo Genitori; Anna Zicca; Andrea Messeri; Matteo Lenge; Flavio Giordano
Journal:  Childs Nerv Syst       Date:  2019-04-26       Impact factor: 1.475

4.  GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.

Authors:  H Teoh; M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Role of endogenous sleep-wake and analgesic systems in anesthesia.

Authors:  Jun Lu; Laura E Nelson; Nick Franks; Mervyn Maze; Nancy L Chamberlin; Clifford B Saper
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

6.  Monoamines as mediators of the antinociceptive effect of baclofen.

Authors:  J Sawynok
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

7.  Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats.

Authors:  Kevin M Hellman; Scott J Mendelson; Marco A Mendez-Duarte; James L Russell; Peggy Mason
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

8.  CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen.

Authors:  M Malcangio; C Ghelardini; A Giotti; P Malmberg-Aiello; A Bartolini
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat.

Authors:  U Sillén; B Persson; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

10.  Hyperpolarization by GABAB receptor agonists in mid-brain periaqueductal gray neurones in vitro.

Authors:  B Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.